Seagen Inc.
ANTIBODIES TO INTEGRIN AVB6 AND USE OF SAME TO TREAT CANCER
Last updated:
Abstract:
The invention provides antibodies that specifically bind to integrin .alpha.v.beta.6. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting .alpha.v.beta.6.
Status:
Application
Type:
Utility
Filling date:
8 Jan 2021
Issue date:
4 Nov 2021